搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
spry
/
财务摘要
ARS Pharmaceuticals Inc
SPRY
添加自选
4.150
USD
-0.030
-0.72%
收盘 09-24 16:00(美东)
412.10M
总市值
亏损
市盈率 TTM
ARS Pharmaceuticals Inc
4.150
-0.030
-0.72%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
SPRY 财务数据
通过专为投资者打造的一站式数据看板,全面查看 ARS Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
412.10M
股息TTM
0.00
市盈率 TTM
-2.07
每股收益TTM
-2.00
营业收入
84.28M
净利润
8.00M
净资产收益率
-136.40%
总资产收益率
-64.39%
ARS Pharmaceuticals Inc 财报日历
最新发布
8月 13, 2026
每股收益 / 预测值
-0.63
/-0.49
营业收入 / 预测值
33.66M
/31.32M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-37.56%
-0.63
-76.38%
-0.61
-181.40%
-0.42
-162.61%
-0.52
-253.02%
-0.46
-224.47%
-0.35
787.61%
0.51
-26.74%
-0.20
29.37%
-0.13
32.82%
-0.11
-114.80%
-0.07
--
-0.16
--
-0.18
--
-0.16
--
0.50
--
-1.76
--
--
--
--
--
--
--
--
营业收入
114.15%
33.66M
184.47%
22.68M
-67.56%
28.09M
1471.62%
32.50M
3043.40%
15.72M
--
7.97M
--
86.58M
--
2.07M
4900.00%
500.00K
-100.00%
0.00
-100.00%
0.00
--
0.00
--
10.00K
--
20.00K
--
1.32M
--
--
--
--
--
--
--
--
--
--
净利润
-38.89%
-62.34M
-78.60%
-60.62M
-182.76%
-41.32M
-167.41%
-51.15M
-258.60%
-44.88M
-229.77%
-33.94M
796.62%
49.93M
-28.67%
-19.13M
27.94%
-12.52M
31.21%
-10.29M
-126.31%
-7.17M
16.78%
-14.87M
10.60%
-17.37M
39.26%
-14.96M
216.12%
27.24M
21.15%
-17.86M
20.69%
-19.43M
-30.55%
-24.63M
-79.29%
-23.46M
--
-22.66M
利润率
35.14%
-185.21%
37.22%
-267.26%
-355.11%
-147.13%
82.98%
-157.38%
88.59%
-285.57%
--
-425.69%
--
57.67%
--
-924.95%
98.56%
-2503.20%
--
--
--
--
--
--
--
-173700.00%
--
-74805.00%
--
2070.06%
--
--
--
--
--
--
--
--
--
--
毛利率
-9.45%
61.83%
-16.22%
72.29%
-21.12%
78.09%
-20.92%
74.80%
-31.71%
68.29%
--
86.28%
--
99.00%
--
94.58%
0.00%
100.00%
--
--
--
--
--
--
--
100.00%
--
100.00%
--
100.00%
--
--
--
--
--
--
--
--
--
--
资产负债率
--
38.75%
--
33.56%
--
29.41%
--
25.81%
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00%
--
--
--
--
--
--
--
--
--
--
利润表
营业收入
114.15%
33.66M
184.47%
22.68M
-67.56%
28.09M
1471.62%
32.50M
3043.40%
15.72M
--
7.97M
--
86.58M
--
2.07M
4900.00%
500.00K
-100.00%
0.00
-100.00%
0.00
--
0.00
--
10.00K
--
20.00K
--
1.32M
--
--
--
--
--
--
--
--
--
--
营业利润
-29.09%
-61.47M
-61.78%
-60.15M
-187.86%
-41.47M
-144.58%
-53.19M
-210.39%
-47.61M
-181.81%
-37.18M
561.54%
47.20M
-20.97%
-21.75M
25.54%
-15.34M
29.50%
-13.19M
-139.48%
-10.23M
2.92%
-17.98M
-10.76%
-20.60M
22.97%
-18.71M
210.18%
25.90M
18.35%
-18.52M
24.11%
-18.60M
-28.64%
-24.29M
-79.43%
-23.51M
--
-22.68M
净利润
-38.89%
-62.34M
-78.60%
-60.62M
-182.76%
-41.32M
-167.41%
-51.15M
-258.60%
-44.88M
-229.77%
-33.94M
796.62%
49.93M
-28.67%
-19.13M
27.94%
-12.52M
31.21%
-10.29M
-126.31%
-7.17M
16.78%
-14.87M
10.60%
-17.37M
39.26%
-14.96M
216.12%
27.24M
21.15%
-17.86M
20.69%
-19.43M
-30.55%
-24.63M
-79.29%
-23.46M
--
-22.66M
资产负债表
流动资产
-24.85%
211.51M
-19.29%
245.24M
-14.78%
284.90M
62.30%
338.86M
27.50%
281.44M
34.31%
303.86M
44.26%
334.30M
-14.59%
208.79M
-13.45%
220.74M
-15.38%
226.24M
-16.56%
231.73M
-9.72%
244.47M
-3.08%
255.03M
2.30%
267.35M
6.20%
277.70M
-11.32%
270.80M
-27.52%
263.13M
-30.93%
261.33M
-33.06%
261.49M
113.26%
305.36M
流动负债总额
33.47%
60.86M
79.61%
49.61M
67.00%
39.15M
206.06%
50.88M
578.05%
45.60M
643.53%
27.62M
880.34%
23.44M
48.69%
16.62M
-33.11%
6.72M
-62.24%
3.71M
-56.08%
2.39M
180.20%
11.18M
-9.77%
10.05M
-33.56%
9.84M
-63.44%
5.44M
-74.00%
3.99M
-28.33%
11.14M
27.71%
14.81M
55.11%
14.89M
91.72%
15.35M
总资产
-20.41%
249.50M
-12.14%
287.57M
-6.69%
327.65M
71.32%
372.80M
41.23%
313.47M
43.82%
327.32M
50.59%
351.15M
-12.45%
217.60M
-14.22%
221.97M
-16.08%
227.58M
-17.14%
233.19M
-8.30%
248.56M
-11.99%
258.75M
-13.21%
271.19M
-15.60%
281.44M
-23.12%
271.06M
-19.89%
294.00M
-18.24%
312.47M
-15.54%
333.47M
136.76%
352.56M
总负债
95.61%
236.98M
130.07%
226.26M
126.16%
213.39M
1254.44%
225.15M
1701.50%
121.15M
2547.21%
98.34M
3786.12%
94.36M
47.47%
16.62M
-34.07%
6.72M
-62.99%
3.71M
-71.60%
2.43M
182.51%
11.27M
-32.93%
10.20M
-47.83%
10.04M
-56.50%
8.55M
-80.47%
3.99M
-12.22%
15.21M
40.95%
19.24M
64.77%
19.65M
92.83%
20.43M
总权益
-93.49%
12.51M
-73.22%
61.31M
-55.51%
114.26M
-26.53%
147.66M
-10.65%
192.32M
2.28%
228.97M
11.28%
256.80M
-15.30%
200.98M
-13.40%
215.24M
-14.28%
223.87M
-15.44%
230.76M
-11.15%
237.28M
-10.85%
248.55M
-10.94%
261.15M
-13.04%
272.89M
-19.59%
267.07M
-20.27%
278.79M
-20.44%
293.23M
-18.04%
313.81M
140.12%
332.13M
现金流量表
经营净额
-53.89%
-60.93M
-10.32%
-44.95M
-203.53%
-43.48M
-225.20%
-47.05M
-443.92%
-39.59M
-507.18%
-40.74M
341.33%
42.00M
-13.35%
-14.47M
56.33%
-7.28M
46.01%
-6.71M
-252.72%
-17.41M
23.02%
-12.76M
-10.01%
-16.67M
37.05%
-12.43M
153.49%
11.40M
13.28%
-16.58M
-7.19%
-15.15M
-61.81%
-19.74M
-92.01%
-21.30M
--
-19.12M
投资净额
-14.41%
41.57M
-4.38%
27.79M
123.70%
24.11M
-367.46%
-44.98M
484.08%
48.57M
441.41%
29.06M
-490.80%
-101.76M
136.06%
16.82M
-128.12%
-12.65M
92.37%
-8.51M
5268.87%
26.04M
-70571.21%
-46.64M
15823.78%
44.97M
-33498.19%
-111.55M
101.89%
485.00K
99.84%
-66.00K
59.14%
-286.00K
-848.57%
-332.00K
-10298.79%
-25.68M
--
-40.06M
融资净额
18.54%
3.20M
-78.07%
159.00K
-98.41%
1.13M
14612.50%
100.05M
394.86%
2.70M
181.01%
725.00K
3828.86%
70.92M
-26.17%
680.00K
-80.90%
545.00K
-80.44%
258.00K
-99.05%
1.81M
-21.95%
921.00K
1953.24%
2.85M
6842.11%
1.32M
68770.55%
189.39M
697.30%
1.18M
-56.43%
139.00K
114.84%
19.00K
-99.89%
275.00K
--
148.00K
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
ARS Pharmaceuticals Inc的总收入是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,总收入达到了84.28M(同比变化89.15M)。
ARS Pharmaceuticals Inc的流动资产是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,流动资产为284.90M(同比变化-14.78)。
ARS Pharmaceuticals Inc的总资产是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,ARS Pharmaceuticals Inc的总资产为327.65M(同比变化-6.69)。
ARS Pharmaceuticals Inc的总负债是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,ARS Pharmaceuticals Inc的总负债为213.39M(同比变化126.16)。
ARS Pharmaceuticals Inc的总权益是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,ARS Pharmaceuticals Inc的总权益为114.26M(同比变化-55.51)。
ARS Pharmaceuticals Inc的净营业收入是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,ARS Pharmaceuticals Inc的净营业收入为-179.45M(同比变化-5720.56)。
ARS Pharmaceuticals Inc的净投资是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,ARS Pharmaceuticals Inc的净投资为56.77M(同比变化153.50)。
ARS Pharmaceuticals Inc的净融资是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,ARS Pharmaceuticals Inc的净融资为104.60M(同比变化44.47)。
ARS Pharmaceuticals Inc的每股收益(EPS)是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-1.74(同比变化-2206.28)。
ARS Pharmaceuticals Inc的净利润是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,净利润为-171.30M(同比变化-2241.76)。
ARS Pharmaceuticals Inc的净利润率是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,净利润率为-203.25(同比变化-2365.55)。
ARS Pharmaceuticals Inc的毛利率是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,毛利率为75.77(同比变化-23.39)。
ARS Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-92.33(同比变化-2914.22)。
ARS Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-50.47(同比变化-1943.71)。
ARS Pharmaceuticals Inc的营业利润是多少?
根据ARS Pharmaceuticals Inc的FY2025财报,营业利润为-179.45M(同比变化-5720.56)。